La Jolla Institute scientist identifies helper cells that trigger potent responses to HIV

Member of National AIDS Vaccine Consortium pinpoints helper T cells important for AIDS vaccine development

2013-09-12

(Press-News.org) SAN DIEGO – (September 12, 2013) A major new finding that will significantly advance efforts to create the world's first antibody-based AIDS vaccine was published today by researchers from the La Jolla Institute for Allergy and Immunology.

La Jolla Institute scientist Shane Crotty, Ph.D., a respected vaccine researcher and member of one of the nation's top AIDS vaccine consortiums, showed that certain helper T cells are important for triggering a strong antibody response against HIV, the virus that causes AIDS. Helper T cells are disease-fighting immune cells key in shaping the body's response to viruses or other pathogens. The cells are multi-faceted, come in various types, and have numerous functions, including assisting with antibody production.

"We've shown that a specific type of these cells, known as follicular helper T (Tfh) cells are not only necessary, but are a limiting factor that differentiates between an average and a potent antibody response to HIV," says Crotty, a scientific collaborator with the Center for HIV/AIDS Vaccine Immunology & Immunogen Discovery (CHAVI-ID), a major research consortium led by The Scripps Research Institute.

Notably, Crotty showed that the frequency of the Tfh cells correlated with development of broadly neutralizing antibodies against HIV in a large group of HIV-infected individuals. The International AIDS Vaccine Initiative put together the group of study participants, and collaborated on the analysis.

Dennis Burton, Ph.D., a prominent HIV expert who heads the CHAVI-ID consortium at Scripps, calls the finding "the kind of fundamental basic research that will eventually allow us to defeat HIV."

"Shane Crotty and his collaborators have made an important step in understanding how potent antibodies to HIV can be made, a step which is vital to the effort to develop an AIDS vaccine given that antibodies are critical to most successful vaccines," says Burton. "Crotty is a world expert on the cells that control antibody production and, by teaming up with AIDS researchers, he and his group have shown how these cells can be tracked in blood and provided evidence of their importance in generating the right types of antibody to HIV."

The findings were published online today in the journal Immunity in a paper entitled, "Human circulating PD-1+CXCR3-CXCR5+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses."

Antibodies may be thought of as the body's smart bombs, which seek out infectious agents and tag them for destruction. Twenty-six human vaccines currently exist worldwide, 24 of which work by triggering the production of antibodies. Tfh cells are a type of CD4+ T helper cells specialized in providing help to B cells, which are the cells that make antibodies. "Essentially it's the Tfh cells that tell the B cells to produce antibodies," explains Crotty.

No vaccine currently exists for HIV (human immunodeficiency virus) and there is no cure for AIDS (acquired immune deficiency syndrome), which currently infects 34 million around the globe. While AIDS drugs have extended the lives of many sufferers, AIDS remains a major killer, particularly in developing countries, making the search for an effective HIV vaccine a public health priority.

In his study, Crotty used blood samples from HIV-infected patients and a control group of people without the disease. As part of his findings, Crotty also developed a robust test for identifying phenotypic markers for Tfh cells in the blood, a major new tool for AIDS researchers. "We found that rare HIV-infected individuals that made outstanding antibodies against HIV had higher levels of a particular kind of Tfh cells circulating in their blood than most people," he says. Further, the study showed a direct correlation between levels of Tfh cells and antibody response. "The higher the levels of Tfh cells, the more significant the antibody response," says Crotty.

Crotty says the ability to measure Tfh cells in the blood will assist AIDS vaccine researchers by serving as an indicator of antibody response. "The question has been, 'how do we make a vaccine that will stimulate those broadly neutralizing antibodies?' The need to elicit Tfh cells is one key piece of that puzzle."

The discovery is Crotty's latest major finding regarding the Tfh cells. In 2009, he drew national attention with his discovery, published in Science, illuminating a pivotal piece of the body's mechanism for switching on the production of antibodies. He proved that the BCL6 gene was like an on and off switch, or master regulator, that triggered the production of Tfh cells, which in turn told the B cells to make more antibodies. This seminal finding led to his recognition as an important scientist in vaccine design, and to his inclusion as a T cell expert in the CHAVI-ID vaccine consortium.

The consortium was one of two nationwide funded by the National Institutes of Health in 2012 in the face of new evidence from The Scripps Research Institute and others that an antibody-based HIV vaccine could be successful.

"For a long time, it wasn't thought possible," explains Crotty. "This was due to a belief that humans just don't make good antibodies against HIV and also because the virus is extremely changeable." But over the years rare individuals began to turn up who appeared capable of making strong antibody responses against HIV. Researchers at Scripps and other institutions began testing blood samples from these individuals in animals and found that they were producing broadly neutralizing antibodies capable of eliminating most of the HIV varieties, says Crotty. Current estimates are that only about five percent of AIDS patients can produce these potent antibodies to HIV, and only multiple years after infection.

In the CHAVI-ID consortium at Scripps, vaccine experts from across the country are collaborating to create an HIV vaccine that will trigger these strong, protective antibodies before infection. The consortium is using an integrated two-pronged approach, with one research group focusing on antibodies and B cells, and the other group exploring the role of T cells in helping B cells produce antibodies, which is Crotty's area of focus.

### About La Jolla Institute Founded in 1988, La Jolla Institute for Allergy and Immunology is a nonprofit, independent biomedical research institute focused on improving human health through increased understanding of the immune system. Its scientists carry out research seeking new knowledge leading to the prevention of disease through vaccines and the treatment and cure of infectious diseases, cancer, inflammatory, and autoimmune diseases such as rheumatoid arthritis, type 1 (juvenile) diabetes, Crohn's disease and asthma. La Jolla Institute's research staff includes more than 150 Ph.D.s and M.D.s. To learn more about the Institute's work, visit http://www.lji.org. END

ELSE PRESS RELEASES FROM THIS DATE:

A microbe's trick for staying young

2013-09-12

Researchers have discovered a microbe that stays forever young by rejuvenating every time it reproduces. The findings, published in Current Biology, provide fundamental insights into the mechanisms of aging. While aging remains an inevitable fact of life, an international team involving researchers from the University of Bristol and the Max-Planck Institute for Molecular Cell Biology and Genetics in Germany has found that this is not the case for a common species of yeast microbe which has evolved to stay young. The team has shown that, unlike other species, the ...

Dali gets a health check: Using medical devices to diagnose art

2013-09-12

Scientists and conservators have developed a new method to diagnose painting canvases from the back, without disturbing a single fibre, to see if they can withstand the stress of handling and travel. Using the method - which is similar to the way doctors measure blood sugar without the need for needles – scientists examined 12 paintings by the surrealist painter Salvador Dalí. They assessed the 'health' of the canvases, which are known to degrade with time due to acidity and environmental conditions. Once a canvas is brittle, expensive conservation is required. While ...

Biologists measure evolution's Big Bang

2013-09-12

A new study led by Adelaide researchers has estimated, for the first time, the rates of evolution during the "Cambrian explosion" when most modern animal groups appeared between 540 and 520 million years ago. The findings, published online today in the journal Current Biology, resolve "Darwin's dilemma": the sudden appearance of a plethora of modern animal groups in the fossil record during the early Cambrian period. "The abrupt appearance of dozens of animal groups during this time is arguably the most important evolutionary event after the origin of life," says lead ...

The peanut at the heart of our galaxy

2013-09-12

One of the most important and massive parts of the galaxy is the galactic bulge. This huge central cloud of about 10 000 million stars spans thousands of light-years, but its structure and origin were not well understood. Unfortunately, from our vantage point from within the galactic disc, the view of this central region — at about 27 000 light-years' distance — is heavily obscured by dense clouds of gas and dust. Astronomers can only obtain a good view of the bulge by observing longer wavelength light, such as infrared radiation, which can penetrate the dust clouds. Earlier ...

Probing methane's secrets: From diamonds to Neptune

2013-09-12

Washington, D.C.—Hydrocarbons from the Earth make up the oil and gas that heat our homes and fuel our cars. The study of the various phases of molecules formed from carbon and hydrogen under high pressures and temperatures, like those found in the Earth's interior, helps scientists understand the chemical processes occurring deep within planets, including Earth. New research from a team led by Carnegie's Alexander Goncharov hones in on the hydrocarbon methane (CH4), which is one of the most abundant molecules in the universe. Despite its ubiquity, methane's behavior ...

Protein essential for maintaining beta cell function identified

2013-09-12

Researchers at the Pediatric Diabetes Research Center (PDRC) at the University of California, San Diego School of Medicine have shown that the pancreatic protein Nkx6.1 – a beta-cell enriched transcription factor – is essential to maintaining the functional state of beta cells. Type 2 diabetes is characterized by impaired insulin secretion by pancreatic beta cells in response to a rise in blood glucose levels. The study, published in the September 26 edition of Cell Reports, shows that loss of NKx6.1 in mice caused rapid onset diabetes. UC San Diego scientists – ...

Molecules pass through nanotubes at size-dependent speeds

2013-09-12

CAMBRIDGE, MA -- Like a pea going through a straw, tiny molecules can pass through microscopic cylinders known as nanotubes. This could potentially be used to select molecules according to size — for example, to purify water by allowing water molecules to pass through while blocking salt or other substances. Now, researchers at MIT, Seoul University in Korea and Ursinus College in Pennsylvania have found that such tubes are more selective than had been thought: Molecules of a precise size can zip through five times faster than those that are a bit smaller or larger. The ...

A century of human impact on Arctic climate indicated by new models, historic aerosol data

2013-09-12

(RENO): The Arctic is the most rapidly warming region of the globe, but warming has not been uniform and the drivers behind this warming not fully understood even during the 20th century. A new study authored by Canadian and American investigators and published in Scientific Reports, a primary research publication from the publishers of Nature, suggests that both anthropogenic and natural factors – specifically sulphate aerosols from industrial activity and volcanic emissions, in addition to greenhouse gas releases from fossil fuel burning – account for Arctic surface ...

Acetylcholine secretion by motor neuron-like cells from UC-MSC

2013-09-12

Basic fibroblast growth factor exhibits a high affinity for heparin. Heparin combined with basic fibroblast growth factor significantly contributes to the differentiation of umbilical cord mesenchymal stem cells into motor neurons. Xueyuan Liu and colleagues from Liaoning Medical University found that the third passage of umbilical cord mesenchymal stem cells induced with heparin and basic fibroblast growth factor exhibited neuronal morphology, and Hb9 expression and acetylcholine levels increased following induction with heparin combined with basic fibroblast growth factor. ...

Does longer sevoflurane preconditioning contribute to better neuroprotective effects?

2013-09-12

Sevoflurane belongs to volatile anesthetics, and preconditioning with sevoflurane has been shown to exert protective effects against ischemic injury in the brain. But the mechanism is unclear. Although studies have shown the neuroprotective effects of sevoflurane preconditioning in the transient cerebral ischemia model, its effect in the permanent focal cerebral ischemia model remains unclear. Dr. Qiu and colleagues from Sichuan University found that 60-minute sevoflurane preconditioning significantly reduced the infarct volume and the number of apoptotic cells in the ischemic ...

La Jolla Institute scientist identifies helper cells that trigger potent responses to HIV

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: